Medivir AB

Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology.

We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Our commercial organization provides a growing portfolio of specialty care pharmaceuticals on the Nordic market. Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Kategorier: Pharma

Gå till Medivir ABs hemsida